SciELO - Scientific Electronic Library Online

vol.6 número3Antidiabéticos en Insuficiencia CardíacaEstándares de calidad en un seguimiento a pacientes ancianos con insuficiencia cardiaca e importante comorbilidad. índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



Links relacionados


Revista Uruguaya de Medicina Interna

versión impresa ISSN 2393-6797versión On-line ISSN 2393-6797


GRANA, Diego et al. Immunosuppressants in Systemic Sclerosis. Use and therapeutic response. Rev. Urug. Med. Int. [online]. 2021, vol.6, n.3, pp.22-30.  Epub 01-Dic-2021. ISSN 2393-6797.


Systemic sclerosis (SS) is a complex and heterogeneous disease. Its therapeutic approach and immunosuppression opportunity is not completely defined, it remains a challenge.


To describe the usage and therapeutic response to immunosuppressive agents (IS) in a cohort of patients with SS.


Patients with SS assisted in 2 units of systemic autoimmune diseases were selected. Those who received IS were included. Variables studied were sex, age and IS indication. Those with respiratory manifestations were assessed with functional lung tests previous and after treatment.


20 patients, 17 females. The mean age was 64 years old. The main indication of IS was respiratory manifestations followed by skin and articular symptoms. Induction treatment was indicated in 75% of respiratory patients vs. 12% in those with other manifestations. Mycophenolate mofetil was the most widely immunosuppressive agent employed.


The main prescription of IS in SS was for patients with respiratory manifestations. An increased use of MMF among other IS was observed as well as a favourable response in lung function tests in patients treated with IS.

Palabras clave : treatment; systemic sclerosis; immunosuppression.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )